Mundipharma specializes in drug production systems and these are applied to our range of treatments in the area of analgesia, ophthalmology, respiratory treatments, among others and we are establishing our presence in the oncology market and beyond.

  • Mundipharma is one of the fastest growing pharmaceutical companies in emerging markets, meeting a growing demand for innovative, patient-centered solutions.

  • This growth is grounded in a strong focus on research and development of new products that challenge current paradigms to improve the quality of life of people around the world.

  • Throughout its more than 60 years of history, Mundipharma has established its presence in 5 continents, with production plants in the United States, United Kingdom, China, Canada, Germany and Cyprus.

  • More than 4 billion patients around the world benefit from Mundipharma treatments.

We are constantly looking for products that complement our current portfolio or offer a viable opportunity for patients in our region. Through our presence and extensive contracts in the Asia-Pacific, Latin America, Middle East and North Africa regions, we can become your allies for the development of the promotion and sales of your product.

Contact us to explore potential collaboration opportunities.
For any request please contact: